The following is a summary of "Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and ...

People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...

The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

The findings from the new study, published in The American Journal of Pathology ... progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

Data from the UDCA group; the clofibrate group showed no significant changes (not shown) in liver function and histology. #, fibrosis was assessed by FibroTest, not by pathology.

Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic ...

both conventional and AI-assisted histology, suggest improvements in fibrosis in patients treated with icosabutate,” said Arun Sanyal, M.D., Director of the Stravitz-Sanyal Institute for Liver ...

The findings from the new study, published in The American Journal of Pathology ... including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring (liver fibrosis), which can ...